Radiotheranostics: A Paradigm Shift in Precision Oncology - Dr. Johannes Czernin

(29:22)

2022 Version - PART 1 - What are radiotheranostics for cancer care?

(3:12)

PART 2 - Doctor, will radiotheranostics make me radioactive?

(2:58)

Miffy Cheng: Customizable multifunctional metal nanotexaphyrin as a radiotheranostics agent

(18:22)

Canadian Radiotheranostics Leaders' Summit - Precision radiopharmaceuticals: What's Next?

(37:29)

Interview with cancer patient Josh Mailman and Family 2024 - treated with radiotheranostics

(46:53)

Canadian Radiotheranostics Leaders' Summit - Porphysome nanotechnology for radiotheranostics

(31:24)

Radioactive Antiques in Thorp Washington

(14:58)

Radiodonts: 'Giants' of the Cambrian

(10:15)

Episode 34 - NET Treatments: Focus on PRRT • Dr. Riham El Khouli

(54:40)

SNMMI 2024 Patient Education Day - Neuroendocrine Tumors (Recorded June 9, 2024)

(1:43:26)

Active Surveillance 2022: Who Qualifies, Who Does Not and How Should it be Monitored

(12:19)

Molecular Imaging and Theranostics of Cancer

(53:2)

Comprehensive Solutions for the Rapidly Advancing Field of Theranostics

(15:32)

Precision Radiopharmaceuticals: What’s Next?

(37:29)

Alpha PSMA \u0026 New Targets in Prostate Cancer | ProsTIC/PCF Global Webinar

(1:28:54)

International day of women in radiopharmaceutical sciences 2024

(1:54)

Just the Beginning: What's Next for Radiotheranostics in Prostate Cancer?

(14:39)

SPLASH Trial Findings: Balancing Enthusiasm and Realities of PSMA Radiotheranostics

(6:15)

How Do Radiohybrid Pharmaceuticals Work?

(2:26)

Canadian Radiotheranostics Leaders' Summit-Where do we go from here? Canadian roadmap for innovation

(44:21)

Canadian Radiotheranostics Leaders' Summit - Nuclear supply chain innovation in medical isotopes

(30:36)

Canadian Radiotheranostics Leaders' Summit - Fireside chat: Wealth creation in nuclear medicine

(20:34)

Nuclear Medicine and Theranostics - with Dr. Patrick Veit-Haibach

(32:53)

How We Use the Mouse Model to Study Radiotherapeutics/Decontamination at LBNL, Alexia Cosby

(41:48)

The ICPO Summit presented today's and tomorrow's clinical relevance of radiotheranostics in oncology

(58)

Canadian Radiotheranostics Leaders' Summit - 2024 Highlights

(2:7)